RIVANNA Wins FDA Clearance for BoneEnhance AI Module on Accuro XV

RIVANNA received FDA 510(k) clearance for BoneEnhance, a machine learning module on its Accuro XV ultrasound system that segments bone and tissues in 3D for musculoskeletal imaging. This marks the first AI software module cleared for the Accuro XV, enhancing image interpretation capabilities.